Dental Care Clinics in Salem, WI Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Fulmer Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7137 236th Ave Ste 108, Salem, WI 53168 Phone: 262-843-4643 |
Jeffrey L. Sorensen, Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 24418 75th St, Salem, WI 53168 Phone: 262-843-2004 |
Jeffrey L Sorensen Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 24418 75th St, Salem, WI 53168 Phone: 262-843-2004 Fax: 262-843-2832 |
News Archive
Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway
Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.
Omega-3 fatty acids for bipolar disorder
Despite intriguing findings that omega-3 fatty acid supplements could alleviate depression symptoms, there is still not enough evidence to say whether omega-3s are useful treatments for people with bipolar disorder, according to a review of recent studies.
Viewpoints: Marketplaces' 'technical foibles' may keep young people from coming back; health law may be ushering in era of narrow networks
The encouraging view is that the overwhelming number of visitors to the site indicates high demand for insurance in the new system. That's critical, because the more people who participate, the better the system works. The danger is that the technical foibles since Oct. 1 will discourage people from coming back, particularly the young and healthy customers the system needs to keep rates reasonable. With some big deadlines approaching, the Obama administration needs to fix the bugs, and fast. People who need insurance from the federal marketplace have until mid-December to buy coverage that begins Jan. 1. If enrollment figures aren't robust by then, the new health-care system will have a problem even bigger than a frustrating Web (10/11).
Trius prices 10,000,000 shares initial public offering
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
› Verified 9 days ago